One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 1.5 million shares of Allogene Therapeutics Inc. (NASDAQ: ALLO) on Tuesday. The price of this ETF was down more than 1% in Tuesday’s session, and it is down a fair amount in the past year.
[in-text-ad]
It was the ARK Genomic Revolution ETF (NYSEARCA: ARKG) that added 1,581,099 shares of Allogene. At Tuesday’s closing price, this would have valued this purchase at roughly $22.6 million. This is only a small fraction of the total holdings. The ETF is down roughly 37% in the past year.
Check out all of ARK Invest’s buys for Tuesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | AMZN | AMAZON.COM | 71 |
| ARKF | PINS | 50 | |
| ARKF | PAGS | PAGSEGURO DIGITAL | 15,747 |
| ARKF | FB | 624 | |
| ARKG | PFE | PFIZER | 80,672 |
| ARKG | ALLO | ALLOGENE THERAPEUTICS | 1,581,099 |
| ARKG | REGN | REGENERON PHARMACEUTICALS | 4,092 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 167,635 |
| ARKK | EDIT | EDITAS MEDICINE | 220,037 |
| ARKK | PRLB | PROTO LABS | 196 |
| ARKQ | JD | JD.COM | 56,925 |
| ARKW | Z | ZILLOW | 1,304 |
| ARKW | SHOP | SHOPIFY | 1,914 |
| ARKW | LPSN | LIVEPERSON | 203,247 |
| ARKW | FTCH | FARFETCH | 1,582 |
| ARKW | FB | 1,973 | |
| ARKX | BA | BOEING | 141 |
| ARKX | HOFP | THALES | 46,027 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.